.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells.
Edited by Thomas A. Waldmann, National Institutes of Health, Silver Spring, MD, and approved May 7, 2014 (received for review March 25, 2014) Interleukin (IL)-15 and its specific receptor chain, IL-15Rα, support the development of various effector cells, including NK and CD8 T cells via a mechanism called trans-presentation. Whereas the dynamic of trans-presentation has been shown to involve the recycling of IL-15Rα by presenting cells, the way responding cells integrate, or take advantage of this process has not been evaluated yet. To address this question, we set up a trans-presentation model using a membrane-bound IL-15.IL-15Rα fusion protein, and found that IL-15 is detectable within responding cells following IL-15 trans-presentation. The role of the proteolytic cleavage of IL-15Rα in this process was investigated by generating an uncleavable form of IL-15Rα. We showed that IL-15 entry into responding cells necessitates the cleavage of IL-15.IL-15Rα complex from the surface of IL-15 presenting cells, and observed that IL-15Rα cleavage is associated with a decrease of the duration of Stat5 signaling. Once separated from presenting cells, responding cells are able to recycle IL-15.IL-15Rα complexes via intracellular compartments, for residual proliferation in a time-limited manner. These studies define an unprecedented cytokine pathway in which the IL-15.IL-15Rα complex cleaved from presenting cells allows responding cells to internalize, store and use IL-15.IL-15Rα complex for their own proliferation and survival.
autocrine | IL-2Rβ | cell-cell interaction | synapse | lymphocyte C ytokines are key molecules involved in a wide variety of lymphocyte functions, including differentiation, proliferation, activation and survival. The way they are regulated impacts on the cell responses and its consequences on the immune system. Interleukin (IL)-15 belongs to the IL-2 cytokine family, which uses in common the gamma chain receptor (CD132). IL-2 and IL-15 are closely related cytokines sharing the same heterodimeric transducing receptor made of IL-2/15Rβ (CD122) and CD132 (1) . The specificity of action of each cytokine is conferred by their private alpha chain, IL-2Rα and IL-15Rα, respectively (2) . Even structurally related, these two receptor chains differ in their potency to bind their cytokine. Whereas IL-2 binds to IL-2Rα-chain with a low affinity (K d = 10 nM), IL-15 retains a high affinity for IL-15Rα (K d = 50 pM). This high affinity allows IL-15 to act in trans-presentation, a mechanism in which membranebound IL-15.IL-15Rα complex interacts and delivers IL-15 signal efficiently to cells expressing the dimeric CD122/CD132 receptor (3). Trans-presentation has been shown to be the dominant mechanism delivering IL-15 signal in vivo, to support the development and the survival of NK cells and CD8 T cells (4, 5) . Prior studies have described the mechanism of establishment of IL-15 trans-presentation in which IL-15 binds to IL-15Rα, playing a role of chaperone, within presenting cells prior from emerging to the cell surface (6) . In this study, to mimic IL-15 and IL-15Rα preassociation, we created a fusion molecule that comprises the total IL-15Rα chain, including the transmembrane domain, covalently linked to IL-15 (wt.ILR). That molecule was routed to the cell surface allowing IL-15 to be trans-presented in the context of membrane anchored IL-15Rα, allowing us to study the fate of the membrane anchored IL-15.IL-15Rα complex following transpresentation.
Numerous studies have described the high degree of regulation of IL-15 expression at transcriptional, translational as well as posttranslational levels. Our laboratory showed that soluble IL-15Rα (sIL-15Rα) could be generated by proteolytic cleavage, acting as a potent antagonist on cell expressing the trimeric IL-15Rα/CD122/CD132 receptor (7) . In contrast, the soluble IL-15Rα could also potentiate IL-15 action, by reinforcing IL-15 binding capacity on the CD122/CD132 dimeric receptor (8) (9) (10) . Thus, we asked whether such a mechanism could participate in the regulation of IL-15 trans-presentation. To address this question, we have identified amino acid residues critical for the cleavage of human IL-15Rα and generated an uncleavable form of this receptor. We have used this uncleavable receptor to examine the role of this proteolytic cleavage in IL-15 signaling.
Results and Discussion

IL-15 Trans-Presentation Is Followed by IL-15 Internalization by
Responding Cells. To investigate the fate of the IL-15.IL-15Rα complex following trans-presentation, stable transfected cell lines (HEK-293) were generated that expressed the membrane-bound IL-15Rα chain. These cells that do not express IL-15 mRNA (Fig. S1A) were cultured with IL-15 overnight to allow IL-15
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Author contributions: E.M. designed research; F.T., I.B., J.H., S.M., and E.M. performed research; A.P. contributed new reagents/analytic tools; F.T., J.H., S.N., S.M., and E.M. analyzed data; and F.T., Y.J., and E.M. wrote the paper. (Fig. 1A) . Kit225 cells also failed to express IL-15 mRNA (Fig. S1A) . IL-15 and IL-15Rα are preformed as complexes in presenting cells in response to stimulation before emerging to the cell surface (6) . To mimic the process of IL-15.IL-15Rα preassociation within the presenting cells, we generated a membrane-bound fusion molecule on which IL-15 is covalently attached via a linker peptide to the N terminus of IL-15Rα. This IL-15-linker-IL-15Rα fusion molecule (herein referred as wt.ILR) was created also to rule out any dissociation of IL-15 as a soluble entity that could act through cis-presentation. IL-15 expression at the surface of transfected cells was checked by flow cytometry (Fig.  S2B) . Using a similar assay as below, wt.ILR transfected cells were cocultured with Kit225 or NK92 cells (ratio 1:1) and the location of IL-15 was analyzed by flow cytometry. We controlled that NK92 cells, like Kit225, did not express IL-15 mRNA (Fig.  S1A) . Surprisingly, after coculture with ILR expressing cells, both Kit225 and NK92 responding cells expressed intracellular IL-15 (Fig. 1B) , suggesting that IL-15 was internalized together with its receptor. This IL-15 entry was strongly diminished by anti-IL-15 antibodies that block IL-15 binding to either the CD122 (MAB247) or CD132 (MAB647) IL-15 receptor chains (Fig. 1C) . To investigate whether these observations could be reproduced with primary cells, we generated monocyte derived immature dendritic cells (iDCs) that were subsequently matured to mDCs by LPS. LPS treatment led to a significant increase of IL-15 expression (Fig. 1D ) that could potentially be presented by the diverse spliced IL-15Rα isoforms recently described (11) . Immature DCs and mDCs were cocultured for 24 h with Kit225 cells. No significant IL-15 could be detected on Kit225 cells after culture with iDCs, whereas significant intracellular IL-15 was observed after culture with mDCs ( Fig. 1E) . Moreover, the level of IL-15 expression on mDCs was simultaneously decreased, reinforcing the idea of a transfer of IL-15 from DCs to Kit225 cells (Fig. 1D, Right) . Altogether, the results obtained with primary DCs validate the physiological relevance of our IL-15 transpresentation model using IL-15Rα and ILR transfected cells. We next investigated whether the IL-15 protein detected inside responding cells was derived from soluble ILR (sILR) released into the culture medium after proteolytic cleavage of its membrane-bound counterpart, or from membrane-bound ILR during cell-cell interaction. To distinguish between these two alternatives, IL-15 presenting cells were physically separated from Kit225 or NK92 responding cells by a transwell insert (TW; Boyden chamber). No IL-15 was detected within either Kit225 or NK92 cells after 24 h of coculture with ILR expressing cells ( Fig. 2A) , minimizing the importance of the soluble IL-15.IL-15Rα complex released during the coculture. These results are in agreement with our previous studies (ref. 6 and Fig. S1C ). IL-15 signaling following trans-presentation was then assessed by measuring Stat5 phosphorylation (12) within responding cells by flow cytometry. Whereas p-Stat5 was induced in Kit225 by coculturing with wt.ILR cells, no signal was detected within Kit225 when separated from wt.ILR using a TW insert, or when cocultured with IL-15Rα cells (Fig.  2B ). This finding indicates that both IL-15 internalization and IL-15 signaling in this in vitro trans-presentation model rely predominantly on membrane-bound ILR.
In parallel, wt.ILR cell culture supernatants were checked for their ability to release soluble IL-15.IL-15Rα complex. These soluble components were detected in the supernatants at low concentrations (10 pM range) that were unable to induce Stat5 phosphorylation within Kit225 cells (Fig. 2E ), compared with that induced by 500 pM sILR (Fig. 2C) . Together, our data indicate that IL-15 trans-presentation leading to IL-15 internalization by responding cells requires cell-cell contact and is not mimicked by soluble IL-15.IL-15Rα complexes released in culture supernatant (3, 6) .
To better understand the physiological importance of IL-15Rα shedding, we attempted to locate the sequence of IL-15Rα responsible for its proteolytic cleavage. Our previous studies Graphs show a pool of at least three independent experiments. ns, not significant; **P < 0.01; ***P < 0.001.
revealed the existence of a soluble IL-15Rα protein, and the apparent molecular mass of this fragment suggested that the proteolytic cleavage site was located in IL-15Rα's extracellular domain close to the plasma membrane (7) . To precisely locate the proteolytic cleavage site, we assayed single amino acid deletions on IL-15Rα. IL-15Rα constructs were generated in which I 178 , S 179 , T 180 , and S 181 were, respectively, deleted and transfected into HEK-293 cell line. Culture supernatants were harvested and sIL-15Rα concentrations were measured by radioactive ELISA. Whereas IL-15Rα shedding was not significantly affected by the I 178 deletion, it was progressively reduced to reach a marked inhibition when S 181 was deleted, without affecting IL-15Rα surface expression ( Fig. 2D and Fig. S2A ). This finding is comparable to that described for the cleavage of IL-6R (13) . Recently, Chertova et al. identified G 170 as the C terminus residue of the naturally cleaved IL-15Rα (14) . However, G 170 belongs to domain 5 of IL-15Rα, and deletion of that domain does not affect the release of soluble IL-15Rα (7). Interestingly, Lorenzen et al. (15) demonstrated that the membraneproximal domain of ADAM17, involved in the shedding of several membrane-bound protein including IL-6R and IL-15Rα, is essential for recognition of the transmembrane proteins substrates. Altogether, these findings suggest that S 181 could belong to a preferential anchoring site on IL-15Rα for its protease or that its deletion induces a conformational change in the membrane proximal domain of IL-15Rα that affects protease anchoring.
IL-15Rα Shedding Is Responsible for the Entry of IL-15 into Responding
Cells. Our identification of S 181 as a critical residue for supporting IL-15Rα cleavage provided a unique opportunity to address the role of IL-15Rα shedding in IL-15 internalization by responding cells during trans-presentation. We generated stably transfected cell lines expressing an uncleavable form of membraneanchored ILR (uc.ILR). Whereas wt.ILR and uc.ILR cells expressed similar amounts of IL-15 at their surface (Fig. S2B) , the S 181 deletion strongly reduced the release of sILR (Fig. 2E) . Using a radio-immunoassay measuring only free soluble IL-15Rα (7), no sIL-15Rα was detected in wt.ILR cell culture supernatant indicating that, even after cleavage of ILR from the membrane, IL-15 stays bound to IL-15Rα (Fig. S2C) . In the trans-presentation assay, whereas a clear intracellular IL-15 signal was detected by flow cytometry inside Kit225 or NK92 cocultured with wt.ILR, it was significantly decreased by threefold at 24 h and fivefold at 48 h when cocultured with uc.ILR (Fig. 3 A and B and Fig. S2E ). The same observation was made using IL-15 loaded wt.IL-15Rα and uc.IL-15Rα (Fig. S2D) . However, IL-15 detection within responding cells cocultured with uc.ILR or IL-15 loaded uc. IL-15Rα was significantly higher compared with wt.IL-15Rα control (Fig. 3B and Fig. S2 D and E) , suggesting that IL-15 entry is not exclusively dependent on IL-15Rα cleavage. This was confirmed by confocal microscopy. When wt.ILR cells were cocultured with CD4 positive Kit225, intracellular IL-15 was detected inside both cell types. Moreover, IL-15 stored into Kit225 seems gathered into clusters (Fig. 3C) . By contrast, IL-15 protein expression inside Kit225 cocultured with uc.ILR cells was strongly reduced (Fig. 3C) IL-15Rα cleavage defective cells were further used to investigate the role of this cleavage in trans-presentation associated signaling. Kit225 cells were added to wt.IL-15Rα or uc.IL-15Rα previously loaded with 100 pM IL-15 and their Stat5 phosphorylation was analyzed by flow cytometry over a 24 h period. P-Stat5 was maintained at a significantly higher level under IL-15 trans-presentation by uc.IL-15Rα than by wt.IL-15Rα (Fig. 4A) . As a negative control, no Stat5 phosphorylation was detectable when Kit225 were cultured with wt.IL-15Rα. That observation was concomitant with a higher maintenance at 24 h of IL-15 expression at the surface of uc.IL-15Rα than of wt.IL-15Rα (Fig. 4B ). To further test the impact of the concentration of IL-15 at the surface of presenting cells, wt. IL-15Rα or uc.IL-15Rα were loaded with increasing concentrations of IL-15. At high (500 pM) IL-15 loading concentration, the percentage of p-Stat5 positive Kit225 induced by wt.IL-15Rα was similar to that induced by uc.IL-15Rα, whereas it was lower by 30% and 50%, respectively, when lower (100 pM and 50 pM) IL-15 loading concentrations were used (Fig. 4C) . This finding suggests that IL-15Rα proteolytic cleavage leads to a limitation of Stat5 phosphorylation caused by an impoverishment of IL-15 at the surface of presenting cells as a result of IL-15 internalization by responding cells. Then, we investigated the impact of the proteolytic cleavage in the context of ILR constructs. Kit225 cells were cocultured with wt.ILR or uc.ILR cells for 1 h and analyzed for pStat5 by flow cytometry. No difference in the level of p-Stat5 was observed (Fig. 4F) , suggesting that internalization of IL-15 is not necessary for its signaling. However, 45% of Kit225 remained positive for Stat5 phosphorylation after 24 h of coculture with uc. ILR cells compared with 23% with wt.ILR cells (Fig. 4D, Left) . As a negative control, no Stat5 phosphorylation was detectable when Kit225 were cultured 1 h or 24 h with wt.IL-15Rα cells. Thus, IL-15Rα cleavage leads to an attenuation of IL-15 signaling with time.
To further examine the impact of IL-15Rα cleavage on the kinetics of IL-15 signaling, we set up a reactivation assay in which Kit225 were stimulated for 3 h with wt.ILR or uc.ILR, and after washing, restimulated with wt.ILR, uc.ILR, or wt.IL-15Rα for 1 h. A higher Stat5 phosphorylation level was confirmed when Kit225 cells were stimulated with uc.ILR compared with wt.ILR (68 vs. 42%, respectively) (Fig. 4E ). When stimulated with wt. ILR and restimulated in the absence of IL-15 (wt.IL-15Rα cells), the percentage of p-Stat5 positive Kit225 dropped from 42% to 12%. As expected, when restimulation was done with wt.ILR, this percentage was maintained to 30%. However, if the cells were restimulated with uc.ILR, it was increased to 54%, indicating again that uc.ILR was able to mobilize more efficiently p-Stat5 than does wt.ILR. In the case of initial stimulation with uc.ILR, restimulation with either wt.ILR or uc.ILR sustained similarly p-Stat5 level to 40%. Altogether, these data indicate that proteolytic cleavage of IL-15Rα during trans-presentation leads to a rapid decrease of Stat5 phosphorylation within responding cells.
The role of CD122 on IL-15 trans-presentation was investigated using the A41 anti-CD122 monoclonal antibody that has been shown to block soluble IL-15 signaling through the CD122/CD132 heterodimeric receptor, but not IL-15 cis-presentation through the IL-15Rα/CD122/CD132 trimeric receptor (18) . Kit225 cells were pretreated with A41, then washed to remove unbound antibody and cocultured with wt.ILR, uc.ILR, or wt.IL-15Rα cells for 1 h before being stained for p-Stat5. Surprisingly, the A41 antibody was unable to block signaling by wt.ILR, whereas it significantly reduced signaling when IL-15 was transpresented by uc.ILR (Fig. 4F) . This finding suggests that in the absence of IL-15Rα cleavage, IL-15 trans-presentation is acting through the CD122/CD132 heterodimeric receptor, whereas the proteolytic cleavage of IL-15Rα makes IL-15 trans-presentation mimics IL-15 cis-presentation through IL-15Rα/CD122/CD132. In the case of the IL-2 system, a sequential assembly of the cytokine to its different receptor chains has been depicted (19, 20) , where initial IL-2 binding to IL-2Rα induces a local conformational change in IL-2 that increases its affinity for CD122. Similarly, IL-15 binds first to IL-15Rα, that association however occurring within the cells prior from emerging at the cell surface, and undergoes an increased affinity for CD122 (6) . This allosteric effect, due to a conformational change in the structure of the IL-15.IL-15Rα complex, was shown to be required for efficient IL-15 trans-presentation (21). Our results suggest that following IL-15 trans-presentation, IL-15Rα cleavage would allow a conformational change in the positioning of the cleaved IL-15Rα within the high-affinity quaternary complex resembling the cis-presentation mode and rendering the A41 binding epitope unavailable.
IL-15 Within Responding Cells Is Essential for Prolonged Cell Survival
by Maintaining a Residual Proliferation. We next tested whether and how IL-15 that entered into responding cells following transpresentation could impact the behavior of these cells. Kit225 or NK92 cells were cocultured with wt.ILR, uc.ILR, or wt.IL-15Rα overnight to allow them to store IL-15.IL-15Rα complexes (Fig.  S2F ). They were then separated from the adherent presenting cells, cultured alone in new medium, and counted 24 h after separation. The number of Kit225 cells increased by twofold when previously cocultured in the presence of wt.ILR cells, whereas it did not change significantly when cultured with either uc.ILR or wt.IL-15Rα cells (Fig. 5A ). In the case of NK92 cells, their number was maintained when precultured with wt.ILR, whereas it decreased significantly by around twofold after uc.ILR or IL-15Rα cells preculture (Fig. 5B) . The same tendency was observed when Kit225 or NK92 were cultured overnight in the presence of sILR, washed, and quantitated at different time points to follow proliferation (Fig. S3A and ref. 22) . Thus, the process of IL-15Rα cleavage linked to trans-presentation and subsequent IL-15.IL-15Rα internalization supports the proliferation and survival of responding cells after their separation from presenting cells. This effect was fully abrogated by A41 Ab (Fig. 5A ), suggesting that it involved an extracellular factor operating through CD122. Given the fact that it was also inhibited by an anti-IL-15 Ab, it is likely due to soluble ILR released by responding cells. Together, these data suggest that once IL-15 responding cells are separated from presenting cells, they switch to another mechanism in which they recycle IL-15.IL-15Rα complexes, previously collected during trans-presentation to continue to proliferate and survive. This recycling process was further documented at the signaling level ( Fig. S3 B and C) . The percentage of p-Stat5 positive Kit225 cells observed at 1 h after Kit225/wt.ILR separation was completely abrogated by the A41 Ab added after cell separation, further indicating that the IL-15.IL-15Rα complex recycling process leading to residual proliferation involves CD122 and Stat5 phosphorylation. This recycling process was also shown to improve cell survival. Indeed, the number of Annexin V-positive responding cells was increased by twofold when precultured in the presence of uc.ILR, compared with wt. ILR (Fig. 5C) . Moreover, as assessed by alamarBlue coloration, NK92 precultured with wt.ILR cells were almost twofold more metabolically active than when precultured with uc.ILR cells (Fig.  5D) . Thus, IL-15.IL-15Rα complexes stored during physical contact lead to improved survival as well as proliferation of responding cells once separated from an IL-15 presenting source. This mechanism could allow the cells to migrate and establish multiple contacts with other IL-15 presenting cells such as mDCs and macrophages (23) . During trans-presentation, as discussed above, a physical contact between presenting and responding cells is the dominant mechanism, and this recycling autocrine process probably plays a secondary role. However, the advantage for responding cells of an IL-15Rα cleavage process leading to such a time controlled autocrine IL-15.IL-15Rα pathway could be to protect them from overexposure to IL-15 signaling. Indeed, overexpression of IL-15 in transgenic mice could lead to fatal leukemia with a T and NK phenotype (24). Uncontrolled expression of IL-15 was described in numerous pathological conditions involving IL-15 autocrine loops (25) (26) (27) (28) (29) (30) . Moreover, soluble IL-15Rα, detected in patients suffering from T-LGL leukemia, could participate to the pathogenesis by decreasing IL-15 response threshold (31) . Altogether, this reinforces the idea of a highly regulated system to protect from such malignant consequences.
In summary, we have identified an unprecedented cytokine pathway by which IL-15.IL-15Rα complexes expressed by presenting cells are internalized following trans-presentation within responding cells. That process is dependent on the proteolytic cleavage of IL-15Rα, which allows IL-15.IL-15Rα complexes to separate from presenting cells and enter into responding cells via the CD122/CD132 receptor. Once inside the responding cells, the IL-15.IL-15Rα complexes accumulate during the time of cell-cell interaction. This process allows responding cells, when separated from presenting cells, to recycle temporarily IL-15. IL-15Rα complexes, previously stored, for residual proliferation (Fig. 6 ). These findings extend our understanding of the complex mode of action of IL-15, and highlight how the immune system can regulate the delivery of a cytokine signal in a highly compartmentalized and time-regulated fashion.
Materials and Methods
Cell Lines, Cytokines, Antibodies. The Kit225 and NK92 cell lines were used in that study. A41 anti-human CD122 antibody was reported previously (32) . See SI Materials and Methods.
Molecular Constructs and Transfections. For mutagenesis, deletions were realized using sequences containing the desired deletion and Quick Change Site-Directed Mutagenesis kit (Stratagene) protocol. After amplification, the sequences were ligated to pcDNA3.1/myc-His mammalian expression vector (Invitrogen) and sequenced. The ILR molecule that comprises the IL-15Rα linked to IL-15 was generated as described (8) . See SI Materials and Methods.
For transfection, cells were transfected following a standard PEI Polyplus transfection protocol. For stable transfections, cells were cloned using a FACS Aria III cytometer (BD Biosciences).
Soluble IL-15Rα and ILR Quantification. The quantification of sIL-15Rα and sILR was determined by Sandwich Radio-Immuno-Assay as described (7) . See SI Materials and Methods.
Flow Cytometry and Immunofluorescence. Intracellular detection of IL-15, p-Stat5 and annexin V staining (BD Biosciences) were assessed according to manufacturer instructions. Cells were analyzed with a Calibur cytometer (BD Biosciences) and FlowJo software. Fluorescent images were acquired using a Nikon A1 RS confocal microscope and analyzed with FIJI and Amira softwares. See SI Materials and Methods.
